Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
IonDX
AddedFeb 16, 2024
UpdatedJun 18, 2026
IonDX

IonDX

Pre-Seed

IonDX: Advanced bioanalytical tools for high-throughput analysis of proteins and biotherapeutics.

HQ
Monterey, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

IonDX, founded by experts with over 40 years of experience in analytical instrumentation, is a bioanalytical instrumentation company focused on revolutionizing the analysis of biologic drugs. The company's core mission is to provide advanced tools for high-throughput analysis of proteins and biotherapeutics. IonDX's innovative ion mobility technology allows scientists to analyze the higher-order structure of proteins and biotherapeutics efficiently, aiming to enhance drug development and research processes.

Notable affiliated individuals include the founding members, who bring decades of expertise in biomacromolecules and nanomaterials. IonDX has achieved significant milestones in developing and patenting its ion mobility technology, positioning itself as a leader in the bioanalytical instrumentation market. The company's impact is evident in its contributions to improving the accuracy and efficiency of protein and biotherapeutic analysis, aiding scientific advancements and fostering innovation in the pharmaceutical industry.

IonDX - Similar Companies

Ionpath logo

Ionpath

BioAnalytix logo

BioAnalytix

bioanalytixinc.com

RedShift BioAnalytics logo

RedShift BioAnalytics

redshiftbio.com

Ionica Sciences logo

Ionica Sciences

IncellDx logo

IncellDx

healthbioai.com

BioAnalytics logo

BioAnalytics

Protein Dynamic Solutions logo

Protein Dynamic Solutions

pdsbio.com

Element Biosciences logo

Element Biosciences

Dnanexus logo

Dnanexus

dnanexus.com

Protea Biosciences logo

Protea Biosciences

proteabio.com

Mobilion Systems logo

Mobilion Systems

Attometrics logo

Attometrics

Andson Biotech logo

Andson Biotech

andsonbiotech.com

GMJ Technologies logo

GMJ Technologies

gmjtechs.com

Fluidigm logo

Fluidigm

standardbio.com

IonDX - Quick Facts

Who are IonDX's competitors?

Companies similar to IonDX include Ionpath, BioAnalytix, RedShift BioAnalytics and Ionica Sciences.

When was IonDX founded?

IonDX was founded in 2014.

Where is IonDX's headquarters located?

IonDX's headquarters is located in Monterey, CA, US.

When was IonDX's last funding round?

IonDX's most recent funding round was for $898.4k (USD) in September 2019.

How much has IonDX raised to-date?

As of Sep 10, 2019, IonDX has raised a total of $1.1M (USD).

How many employees does IonDX have?

IonDX has 8 employees as of Feb 4, 2024.

IonDX - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Analytical Instruments
  • Bioanalytical Instruments
Tags
  • Biotech
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software